Abstract | BACKGROUND: METHODS: A total of 1932 consecutive patients with T2DM and AMI were enrolled in this study. Patients were divided into tertiles according to their TyG index levels. The incidence of major adverse cardiac and cerebral events (MACCEs) was recorded. The TyG index was calculated as the ln [fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2]. RESULTS: Competing risk regression revealed that the TyG index was positively associated with CV death [2.71(1.92 to 3.83), p < 0.001], non-fatal MI [2.02(1.32 to 3.11), p = 0.001], cardiac rehospitalization [2.42(1.81 to 3.24), p < 0.001], revascularization [2.41(1.63 to 3.55), p < 0.001] and composite MACCEs [2.32(1.92 to 2.80), p < 0.001]. The area under ROC curve of the TyG index for predicting the occurrence of MACCEs was 0.604 [(0.578 to 0.630), p < 0.001], with the cut-off value of 9.30. The addition of TyG index to a baseline risk model had an incremental effect on the predictive value for MACCEs [net reclassification improvement (NRI): 0.190 (0.094 to 0.337); integrated discrimination improvement (IDI): 0.027 (0.013 to 0.041); C-index: 0.685 (0.663 to 0.707), all p < 0.001]. CONCLUSIONS: The TyG index was significantly associated with MACCEs, suggesting that the TyG index may be a valid marker for risk stratification and prognosis in patients with T2DM and AMI. Trial registration Retrospectively registered.
|
Authors | Yue Zhang, Xiaosong Ding, Bing Hua, Qingbo Liu, Hui Gao, Hui Chen, Xue-Qiao Zhao, Weiping Li, Hongwei Li |
Journal | Cardiovascular diabetology
(Cardiovasc Diabetol)
Vol. 20
Issue 1
Pg. 43
(02 11 2021)
ISSN: 1475-2840 [Electronic] England |
PMID | 33573649
(Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Blood Glucose
- Triglycerides
|
Topics |
- Aged
- Biomarkers
(blood)
- Blood Glucose
(metabolism)
- China
- Databases, Factual
- Diabetes Mellitus, Type 2
(blood, diagnosis, mortality, therapy)
- Female
- Heart Disease Risk Factors
- Humans
- Incidence
- Insulin Resistance
- Male
- Middle Aged
- Myocardial Infarction
(blood, diagnostic imaging, mortality, therapy)
- Prognosis
- Risk Assessment
- Time Factors
- Triglycerides
(blood)
|